Erman Akkus, Medical Oncology Fellow at Ankara University, shared an article by Sirui Tan, et al. on X:
“DDR mutations and outcome in biliary tract cancers.
- DDR-positive vs. DDR-negative
- With platinum-based ChT or with chemoimmunotherapy- ORR increases, PFS increases, OS increases.
DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer.
Authors: Sirui Tan, et al.
